CDKN1C anticorps (N-Term)

N° du produit ABIN1804211

L’anticorps anti-CDKN1C Polyclonal Lapin est utilisé pour la détection de CDKN1C dans des échantillons de Humain. Il a été validé pour WB, IHC et IHC (p).

Aperçu rapide pour CDKN1C anticorps (N-Term) (ABIN1804211)

Antigène: CDKN1C (Cyclin-Dependent Kinase Inhibitor 1C (p57, Kip2) (CDKN1C))

Reactivité: Humain

Hôte: Lapin

Clonalité: Polyclonal

Conjugué: Cet anticorp CDKN1C est non-conjugé

Application: Western Blotting (WB), Immunohistochemistry (IHC), Immunohistochemistry (Paraffin-embedded Sections) (IHC (p))

Détail du produit anti-CDKN1C anticorps

Épitope: N-Term

Specificité: At least three isoforms of CDKN1C are known to exist, this antibody will detect all three isoforms. Despite its predicted molecular weight, CDKN1C often migrates at 57  kDa in SDS-PAGE. CDKN1C antibody is predicted to not cross react with other CIP/KIP proteins.

Purification: Immunoaffinity purified

Isotype: IgG

Information d'application

Indications d'application: Approved: IHC, IHC-P (5 μg/mL), WB (1 - 2 μg/mL)

Usage: CDKN1C antibody can be used for detection of CDKN1C by Western blot at 1-2 μg/mL.

Commentaires:

Target Species of Antibody: Human

Restrictions: For Research Use only

Stockage

Format: Liquid

Concentration: Lot specific

Buffer: PBS, 0.02 % sodium azide

Agent conservateur: Sodium azide

Précaution d'utilisation: This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Conseil sur la manipulation: Avoid repeated freezing and thawing.

Stock: 4 °C,-20 °C

Stockage commentaire: Store at 4°C for 3 months and -20°C, stable for up to 1 year. Avoid repeated freeze-thaw cycles.

Date de péremption: 12 months

Détails sur CDKN1C

Antigène: CDKN1C (Cyclin-Dependent Kinase Inhibitor 1C (p57, Kip2) (CDKN1C))

Autre désignation: CDKN1C / p57 Kip2

Sujet: Name/Gene ID: CDKN1C

Synonyms: CDKN1C, BWS, KIP2, IMAGE, p57Kip2, p57, p57 KIP2, Beckwith-Wiedemann syndrome, WBS, BWCR

ID gène: 1028

UniProt: P49918

Pathways: Cycle Cellulaire, Dopaminergic Neurogenesis